Endo has announced the decision to cease the production and sale of Endo Aesthetics' Qwo® (collagenase clostridium histolyticum-aaes). After careful consideration, we have determined that QWO does not represent a viable commercial opportunity for Endo. Read the press release here.
QWO Return Goods Program:
The QWO Return Goods Program ended on March 31, 2023.
Endo made a good faith effort to communicate with as many customers as possible based on information provided in the IGNITE training portal. Communications were sent in both December 2022 and January 2023 and clearly specified that the Program ran only through March 31, 2023, and that all product eligible for return had to be physically received by McKesson by March 31, 2023, otherwise no refund or credit would be given. This information was also provided publicly via press release and company websites.
McKesson can no longer process returns at this time, per the terms and conditions of the Program, and the Program cannot be re-opened.
For medical inquiries, please contact Endo Medical Information at 1-800-462-ENDO (3636) from 9 a.m. to 8 p.m. ET Monday through Thursday or from 9 a.m. to 6 p.m. ET on Friday.
Credits and Refunds:
All eligible product meeting the terms and conditions of the program have been refunded. Please check the McKesson Customer Center to manage your credit and apply it toward balances or future McKesson purchases.
If you need further assistance related to your credit, including requesting your credit in a different form (refund via check or credit card, for example), email 3plfinancialservices@mckesson.com.
Claims:
If you believe you have a claim against Endo that arose on or prior to August 16, 2022, relating to an Endo Aesthetics Product, you may file a claim in Endo's bankruptcy proceedings. Please visit https://restructuring.ra.kroll.com/endo and follow the instructions under the link entitled "Submit a Claim." You may also consult with an attorney regarding your options.
Please note that the bankruptcy court has set deadlines for parties to file claims against Endo. The general bar date (deadline) is 5 PM ET on July 7, 2023. If you believe you have a prepetition claim against Endo based on an injury relating to a product of Endo Pharmaceuticals Inc. or Endo Aesthetics LLC, you must file your claim by the deadline or you will lose any right to seek payment or compensation you may have had.
Medical Inquiries:
For medical inquiries, please contact Endo Medical Information at 1-800-462-ENDO (3636) from 9 a.m. to 8 p.m. ET Monday through Thursday or from 9 a.m. to 6 p.m. ET on Friday.